http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210035425-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b3e6d8f05d9475eab2cebb5c85f9f80 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate | 2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9258a218d7e81596f6bf791c3a6198ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac1f09639c888764268297abad52cfb |
publicationDate | 2021-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20210035425-A |
titleOfInvention | N-Allyl-2-[(6-butyl-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-5-yl)sulfanyl]acetamide for treating and preventing anxiety or Neuroinflammatory diseases |
abstract | The present invention is N-aryl-2-[(6-butyl-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine- It relates to a pharmaceutical composition for the prevention and treatment of anxiety disorders or neuroinflammatory diseases containing 5-yl)sulphenyl]acetamide as an active ingredient, and the N-aryl-2-[(6-butyl-1,3) of the present invention -Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-yl)sulphenyl]acetamide is CHI3L1 (Chitinase 3-like 1) It can be used as a composition for preventing and treating anxiety symptoms or neuro-inflammatory diseases because it binds to inhibit function and relieves nerve inflammation to improve anxiety symptoms. |
priorityDate | 2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.